We fight for human health.

CureVac is the first company to successfully harness messenger RNA (mRNA) for medical purposes. The principle is promising: use natural mRNA as a data carrier to instruct the human body to produce its own proteins to fight a wide range of diseases.

  • CureVac to Receive Patent Claiming the Combination of mRNA Vaccines with Anti-PD-1 Antibodies

    Press Release of July 20, 2017

    Read more
  • Watch our new mode of action video

    Whatever message your body needs to heal itself – we at CureVac have the expertise to write this medical message on mRNA

    Read more
  • CureVac Expands GMP Production Capacities for RNA Products

    Press Release of June 26, 2017

    Read more
  • CureVac Extends Global Intellectual Property Estate for Prophylactic mRNA Vaccines

    Press Release of June 13, 2017

    Read more
  • Save the Date for the 5th International mRNA Health Conference

    November 1-2, 2017, Berlin, Germany

    Read more
  • Work@CureVac

    Do you want to fight together with us for human health? You will find current vacancies on our CareerPortal.

    Read more